Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serhat Unal

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Vaccines|November 11, 2022
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III TrialMine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, et al.
International Journal of Cancer|September 9, 2022
Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapyDeniz Can Guven, Fatma Gul Gulbahce Incesu, Hasan Cagri Yildirim, et al.
Current Medical Research and Opinion|September 19, 2017
Poor outcomes among elderly patients hospitalized for influenza-like illnessMine Durusu Tanriover, Tülay Bagci Bosi, Lale Ozisik, et al.
International Journal of Antimicrobial Agents|August 4, 2023
Macrolides for better resolution of community-acquired pneumonia: A global meta-analysis of clinical outcomes with focus on microbial aetiologyMiltiades Kyprianou, Konstantina Dakou, Aftab Aktar, et al.
Emerging Infectious Diseases|March 12, 2011
Livestock-associated methicillin-resistant Staphylococcus aureus in humans, EuropeBrigitte A G L van Cleef, Dominique L Monnet, Andreas Voss, et al.
Lancet (London, England)|July 11, 2021
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in TurkeyMine Durusu Tanriover, Hamdi Levent Doğanay, Murat Akova, et al.
Annals of Clinical Microbiology and Antimicrobials|November 19, 2014
International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003-2012Hakan Leblebicioglu, Nurettin Erben, Victor Daniel Rosenthal, et al.
The Journal of Infectious Diseases|August 1, 2023
Predictors of Severity of Influenza-Related Hospitalizations: Results From the Global Influenza Hospital Surveillance Network (GIHSN)Lily E Cohen, Chelsea L Hansen, Melissa K Andrew, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 14, 2013
Mortality indicators in community-acquired pneumonia requiring intensive care in TurkeyHakan Erdem, Hulya Turkan, Aykut Cilli, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul studyHakan Erdem, Aysegül Ulu-Kilic, Selim Kilic, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Vaccines|November 11, 2022
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III TrialMine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, et al.
International Journal of Cancer|September 9, 2022
Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapyDeniz Can Guven, Fatma Gul Gulbahce Incesu, Hasan Cagri Yildirim, et al.
Current Medical Research and Opinion|September 19, 2017
Poor outcomes among elderly patients hospitalized for influenza-like illnessMine Durusu Tanriover, Tülay Bagci Bosi, Lale Ozisik, et al.
International Journal of Antimicrobial Agents|August 4, 2023
Macrolides for better resolution of community-acquired pneumonia: A global meta-analysis of clinical outcomes with focus on microbial aetiologyMiltiades Kyprianou, Konstantina Dakou, Aftab Aktar, et al.
Emerging Infectious Diseases|March 12, 2011
Livestock-associated methicillin-resistant Staphylococcus aureus in humans, EuropeBrigitte A G L van Cleef, Dominique L Monnet, Andreas Voss, et al.
Lancet (London, England)|July 11, 2021
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in TurkeyMine Durusu Tanriover, Hamdi Levent Doğanay, Murat Akova, et al.
Annals of Clinical Microbiology and Antimicrobials|November 19, 2014
International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003-2012Hakan Leblebicioglu, Nurettin Erben, Victor Daniel Rosenthal, et al.
The Journal of Infectious Diseases|August 1, 2023
Predictors of Severity of Influenza-Related Hospitalizations: Results From the Global Influenza Hospital Surveillance Network (GIHSN)Lily E Cohen, Chelsea L Hansen, Melissa K Andrew, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 14, 2013
Mortality indicators in community-acquired pneumonia requiring intensive care in TurkeyHakan Erdem, Hulya Turkan, Aykut Cilli, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul studyHakan Erdem, Aysegül Ulu-Kilic, Selim Kilic, et al.
Pageof 11